Noze

Noze has developed a digital olfaction platform that uses AI-powered sensors to detect disease biomarkers from breath samples. Their lead product, DiagNoze®, is a handheld diagnostic device designed for rapid, non-invasive detection of infectious diseases and other health conditions at the point of care. The company has demonstrated successful prototypes and secured significant funding—including equity investment from the Bill & Melinda Gates Foundation—to advance clinical validation and deployment in low-resource settings. Clinical results are promising but full regulatory approval/commercialization status is not yet public.